26987067|t|Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?
26987067|a|Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) regulates the expression of low-density lipoprotein (LDL)-receptors, through reducing their recycling by binding to the receptor along with LDL and targeting it for lysosomal destruction. PCSK9 also enhances the degradation of very-low-density-lipoprotein receptor (VLDLR) and lipoprotein receptor-related protein 1 (LRP-1) in a LDL-receptor independent manner. This role in lipid homeostasis presents PCSK9 as an attractive target for the therapeutic management of familial hypercholesterolemia as well as other refractory dyslipidaemias. However, PCSK9 mediates multifarious functions independent of its role in lipid homeostasis, which can be grouped under "pleiotropic functions" of the protein. This includes PCSK9's role in: trafficking of epithelial sodium channel; hepatic regeneration; pancreatic integrity and glucose homeostasis; antiviral activity; antimalarial activity; regulation of different cell signalling pathways; cortical neural differentiation; neuronal apoptosis and Alzheimer's disease. The question that needs to be investigated in depth is "How will the pleotropic functions of PCSK9, be affected by the therapeutic intervention of the protease's LDL-receptor lowering activity?" In this review, we appraise the different lipid lowering strategies targeting PCSK9 in light of the protein's different pleiotropic functions. Additionally, we delineate the key areas that require further examination, to ensure the long-term safety of the above lipid-lowering strategies. 
26987067	10	15	PCSK9	Gene	255738
26987067	75	120	Proprotein Convertase Subtilisin/Kexin Type 9	Gene	255738
26987067	122	127	PCSK9	Gene	255738
26987067	317	322	PCSK9	Gene	255738
26987067	356	393	very-low-density-lipoprotein receptor	Gene	7436
26987067	395	400	VLDLR	Gene	7436
26987067	406	444	lipoprotein receptor-related protein 1	Gene	4035
26987067	446	451	LRP-1	Gene	4035
26987067	458	470	LDL-receptor	Gene	3949
26987067	504	509	lipid	Chemical	MESH:D008055
26987067	531	536	PCSK9	Gene	255738
26987067	595	624	familial hypercholesterolemia	Disease	MESH:D006938
26987067	653	667	dyslipidaemias	Disease	
26987067	678	683	PCSK9	Gene	255738
26987067	743	748	lipid	Chemical	MESH:D008055
26987067	843	848	PCSK9	Gene	255738
26987067	886	892	sodium	Chemical	MESH:D012964
26987067	949	956	glucose	Chemical	MESH:D005947
26987067	1096	1114	neuronal apoptosis	Disease	MESH:D065703
26987067	1119	1138	Alzheimer's disease	Disease	MESH:D000544
26987067	1233	1238	PCSK9	Gene	255738
26987067	1302	1314	LDL-receptor	Gene	3949
26987067	1377	1382	lipid	Chemical	MESH:D008055
26987067	1413	1418	PCSK9	Gene	255738
26987067	1597	1602	lipid	Chemical	MESH:D008055
26987067	Negative_Correlation	255738	4035
26987067	Association	MESH:D000544	255738
26987067	Association	MESH:D065703	255738
26987067	Association	MESH:D012964	255738
26987067	Association	MESH:D008055	255738
26987067	Association	MESH:D006938	255738
26987067	Association	MESH:D005947	255738
26987067	Negative_Correlation	255738	7436

